- Home
- JOB vs LIXT Comparison
JOB vs LIXT Comparison
Compare JOB & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOB
- LIXT
- Stock Information
- Founded
- JOB 1893
- LIXT 2005
- Country
- JOB United States
- LIXT United States
- Employees
- JOB N/A
- LIXT N/A
- Industry
- JOB Diversified Commercial Services
- LIXT Biotechnology: Pharmaceutical Preparations
- Sector
- JOB Consumer Discretionary
- LIXT Health Care
- Exchange
- JOB Nasdaq
- LIXT Nasdaq
- Market Cap
- JOB 22.5M
- LIXT 20.5M
- IPO Year
- JOB N/A
- LIXT N/A
- Fundamental
- Price
- JOB $0.20
- LIXT $4.28
- Analyst Decision
- JOB
- LIXT
- Analyst Count
- JOB 0
- LIXT 0
- Target Price
- JOB N/A
- LIXT N/A
- AVG Volume (30 Days)
- JOB 223.8K
- LIXT 133.0K
- Earning Date
- JOB 12-18-2025
- LIXT 11-07-2025
- Dividend Yield
- JOB N/A
- LIXT N/A
- EPS Growth
- JOB N/A
- LIXT N/A
- EPS
- JOB N/A
- LIXT N/A
- Revenue
- JOB $108,752,000.00
- LIXT N/A
- Revenue This Year
- JOB $43.94
- LIXT N/A
- Revenue Next Year
- JOB N/A
- LIXT N/A
- P/E Ratio
- JOB N/A
- LIXT N/A
- Revenue Growth
- JOB N/A
- LIXT N/A
- 52 Week Low
- JOB $0.17
- LIXT $0.64
- 52 Week High
- JOB $0.51
- LIXT $6.26
- Technical
- Relative Strength Index (RSI)
- JOB 45.34
- LIXT 43.97
- Support Level
- JOB $0.19
- LIXT $4.18
- Resistance Level
- JOB $0.21
- LIXT $4.42
- Average True Range (ATR)
- JOB 0.01
- LIXT 0.39
- MACD
- JOB -0.00
- LIXT -0.06
- Stochastic Oscillator
- JOB 53.82
- LIXT 34.91
About JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.